NEXGEL INC (NXGL) Stock Price, Forecast & Analysis
NASDAQ:NXGL • US65344E1073
NXGL Key Statistics, Chart & Performance
The current stock price of NXGL is 1.28 USD. In the past month the price decreased by -16.88%. In the past year, price decreased by -61.45%.
NXGL Technical Analysis
NXGL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to NXGL. NXGL may be in some trouble as it scores bad on both profitability and health.
NXGL Financial Highlights
Over the last trailing twelve months NXGL reported a non-GAAP Earnings per Share(EPS) of -0.37. The EPS increased by 38.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -24.78% | ||
| ROE | -55.53% | ||
| Debt/Equity | 0.15 |
NXGL Forecast & Estimates
7 analysts have analysed NXGL and the average price target is 6.12 USD. This implies a price increase of 378.13% is expected in the next year compared to the current price of 1.28.
For the next year, analysts expect an EPS growth of 28.6% and a revenue growth 37.34% for NXGL
NXGL Ownership
NXGL Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 31.9 | 60.641B | ||
| COO | COOPER COS INC/THE | 18.28 | 16.059B | ||
| ALGN | ALIGN TECHNOLOGY INC | 17.03 | 13.433B | ||
| SOLV | SOLVENTUM CORP | 11.57 | 12.789B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 20.11 | 4.837B | ||
| LNTH | LANTHEUS HOLDINGS INC | 12.93 | 4.726B | ||
| ICUI | ICU MEDICAL INC | 18.49 | 3.661B | ||
| HAE | HAEMONETICS CORP/MASS | 11.05 | 2.723B | ||
| XRAY | DENTSPLY SIRONA INC | 8.02 | 2.482B | ||
| NEOG | NEOGEN CORP | 32.88 | 2.391B |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About NXGL
Company Profile
NexGel, Inc. engages in the manufacture of aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Langhorne, Pennsylvania and currently employs 19 full-time employees. The company went IPO on 2021-12-22. The company is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The firm operates through two segments: NexGel and CGN. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CGN segment comprises CG Converting and Packaging, LLC (CGN), a joint venture with C.G. Laboratories Inc. (CG Labs) used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Silly George.
Company Info
NEXGEL INC
2150 Cabot Blvd West,, Suite B
Langhorne PENNSYLVANIA US
Employees: 19
Phone: 12157028550
NEXGEL INC / NXGL FAQ
What does NEXGEL INC do?
NexGel, Inc. engages in the manufacture of aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Langhorne, Pennsylvania and currently employs 19 full-time employees. The company went IPO on 2021-12-22. The company is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The firm operates through two segments: NexGel and CGN. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CGN segment comprises CG Converting and Packaging, LLC (CGN), a joint venture with C.G. Laboratories Inc. (CG Labs) used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Silly George.
What is the stock price of NEXGEL INC today?
The current stock price of NXGL is 1.28 USD. The price decreased by -1.54% in the last trading session.
Does NEXGEL INC pay dividends?
NXGL does not pay a dividend.
What is the ChartMill technical and fundamental rating of NXGL stock?
NXGL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the sector and industry classification for NEXGEL INC?
NEXGEL INC (NXGL) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
How many employees does NEXGEL INC have?
NEXGEL INC (NXGL) currently has 19 employees.
What is the market capitalization of NXGL stock?
NEXGEL INC (NXGL) has a market capitalization of 10.42M USD. This makes NXGL a Nano Cap stock.